New Constructs argues Anthropic's rumored $2 trillion IPO valuation is drastically overpriced, valuing the company at only ~$150 billion based on massive operating losses ($8B in 2025), $518B in infrastructure commitments, and lack of competitive moat as open-source models compete. The IPO represents primarily insider liquidity rather than a sound investment, with early investors looking to cash out shares at inflated valuations to retail investors.

User lost $2M in a year through high-risk strategies including 0DTE options, penny biotech stocks, and leveraged positions, then recovered most losses through large-cap tech plays. Key lessons: avoid 0DTE options with significant capital, don't overconfidently trade penny biotech, and don't bet against Fed policy.

Humorous post comparing personal options trading performance against a squirrel's random selection across SPY, QQQ, AAPL, GOOGL, and NVDA options. The author is conducting a semi-serious experiment tracking 50-100 trades to determine if random selection outperforms their technical analysis.

Nike is undervalued despite high P/E ratio because quality companies command premium valuations; the company is actively investing in next-generation athlete partnerships (like Alyssa Liu) that will drive long-term growth similar to Apple's strategy. Key risks include competitive pressure from Lululemon, execution risk on new partnerships, and market sentiment shifts.

Developer created a native iOS/watchOS app for real-time gold and silver price tracking with a clean interface. The app addresses gaps in existing solutions by offering accurate, frequently-updated precious metals pricing directly on iPhone and Apple Watch.

Apple's 2024 product lineup failed to deliver meaningful innovation despite premium pricing, with consumers paying high prices for incremental upgrades rather than transformative features. The post critiques Apple's strategy of charging premium prices for evolutionary rather than revolutionary improvements, suggesting shareholders may face disappointing returns.

Intel is severely overvalued at $125 with a 904x trailing P/E, negative net income (-$3.17B TTM), and negative FCF (-$8.3B), driven by unsustainable hype around a politically-pressured Apple preliminary deal that lacks official confirmation. The core thesis of Intel Foundry becoming a TSMC alternative is flawed due to yield problems (50-55% vs TSMC's 65-70%+) and delayed product launches, making the stock a bubble waiting to burst.

Intel stock has rallied 594% on weak fundamentals including negative net income (-$3.17B TTM), negative FCF (-$8.3B), and a 904x trailing P/E, driven primarily by a preliminary Apple deal that the author argues is politically motivated theater rather than organic demand. The foundry business thesis is flawed due to low yields (50-55% vs TSMC's 65-70%+), delayed products, and inability to compete with TSMC, making current valuations completely disconnected from reality.

Meta (META) now trades at a more attractive valuation compared to Apple (AAPL), with potentially better growth prospects and lower valuation multiples. Key risks include regulatory headwinds for Meta, competitive pressures in AI/metaverse, and broader tech sector cyclicality.

Berkshire Hathaway (BRK.B) is identified as a trillion-dollar company trading at a 14 P/E ratio, considered undervalued compared to Apple at all-time highs. The thesis targets $500+ price with technical support at the weekly 100 EMA, though lacks detailed fundamental analysis or catalysts to support the price target.